Smithfield Trust’s Prothena Corp PRTA Stock Holding History

Smithfield Trust’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-14	Closed	–	–	854
2013 Q4	$0	Hold	14	–	–	﹤0.01%	839
2013 Q3	$0	Hold	14	–	–	﹤0.01%	763
2013 Q2	$0	Buy	+14	New	+$130	﹤0.01%	730

Other funds holding PRTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Smithfield Trust's PRTA Position: Q1 2014 in Review

Smithfield Trust sold out of Prothena Corp (PRTA) in Q1 2014, closing a stake of 14 shares.

Smithfield Trust first reported a position in PRTA in Q2 2013 and held it in 3 quarters. The position peaked at $0 in Q4 2013. 118 funds tracked by Wall St. Rank hold PRTA as of Q1 2014.

Smithfield Trust reported no remaining Prothena Corp position as of Q1 2014 after selling out during the quarter.
Smithfield Trust sold 14 Prothena Corp shares in Q1 2014.
Smithfield Trust first reported a position in Prothena Corp in Q2 2013 and held it in 3 quarters.
Smithfield Trust's Prothena Corp position peaked at $0 in Q4 2013.
118 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2014.

Based on Smithfield Trust's 13F filing for Q1 2014, filed 6 May 2014.